AbOliGo

AbOliGo is a biotechnology company developing antibody-oligonucleotide conjugates (AOCs) for multiplexed protein analysis, spatial biology and single-cell workflows.

Its conjugation platform addresses a critical bottleneck in multiomic research, as fewer than 0.1% of commercially available antibodies are currently offered as AOCs.

The platform is compatible with major spatial biology and proteomics instruments, enabling researchers to convert existing antibodies into multiomic-ready reagents with improved reproducibility and scalability.